z-logo
open-access-imgOpen Access
Gene therapy targeting the blood–brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency
Author(s) -
Sivaraj Mohana Sundaram,
Adriana Arrulo Pereira,
Helge MüllerFielitz,
Hannes Köpke,
Meri De Angelis,
Timo D. Müller,
Heike Heuer,
Jakob Körbelin,
Markus Krohn,
Jens Mittag,
Rubén Nogueiras,
Vincent Prévot,
Markus Schwaninger
Publication year - 2022
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awac243
Subject(s) - monocarboxylate transporter , hormone , thyroid , blood–brain barrier , genetic enhancement , disease , medicine , endocrinology , bioinformatics , neuroscience , transporter , gene , psychology , central nervous system , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom